Boomerang Medical

Boomerang Medical

Private
Mountain View, CaliforniaHealthcare & Life Scienceshttps://www.boomerangmedical.com

Last Round

Series B

Sep 4, 2025

Total Funding Raised

$38M

Company Overview

Boomerang Medical, Inc. is a privately-held, clinical-stage bioelectronic medicine company focused on developing treatments for autoimmune diseases. Founded in 2021 and led by CEO Heather Simonsen, the company is pioneering neuromodulation therapies, with an initial focus on Inflammatory Bowel Disease (IBD), including Crohn's disease and ulcerative colitis. Its technology, which has received Breakthrough Device Designation from the FDA, aims to regulate the body's immune response by stimulating specific nerve pathways. The company is headquartered in Mountain View, California, and is a Company-In-Residence at the Fogarty Innovation incubator. Boomerang Medical has raised significant venture funding, including a $20 million Series B round in September 2025, to advance its pivotal clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Non-AI

Keywords

bioelectronic medicineneuromodulation therapyimplantable medical deviceelectroceuticalssacral neuromodulationSNMinflammatory bowel diseaseIBDFDA Breakthrough DeviceCrohn's diseaseulcerative colitisperipheral nerve stimulationautoimmune disease treatmentnon-pharmacologic treatmentgastroenterology device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Boomerang Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Boomerang Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BSep 4, 2025
Series ANov 1, 2022
SeedOct 18, 2021

Key People

Founding team and executive leadership

David Miller

Chief Technology And Innovation Officer, Co-founder

Founding Team

Heather Simonsen

Chief Executive Officer Board Member

Executive Team

Boomerang Medical Investors

Notable investors and investment history

InvestorRounds
Arboretum VenturesSeries A, Series B, Seed
Hatteras Venture PartnersSeries A, Series B
Fogarty InnovationSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 4, 2025

    $20M round completed.

Boomerang Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Boomerang Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Boomerang Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersMountain View, California
Employee Range15
Year Founded2021
Last FundingSep 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.